Class II and III obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
The treatment was divided into two stages: Stage One (inpatient treatment
3 weeks)
Stage Two (outpatient treatment
48 weeks).
Participants started the assigned diet on the second inpatient day, and continued it during the whole Stage Two. They were admitted in consecutive blocks of 8, all following the same diet
Sponsors
Regional Agency for Health and Social Care, Regione Emilia-Romagna (Italy)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age range 18-65 years 2. Body mass index (BMI) = 40.0 kg/m2 or between 35 and 39.9 with at least one weight loss-responsive comorbidity (e.g., type 2 diabetes, cardiovascular diseases, sleep apnea, severe joint disease, two or more risk factors defined by the Adult Treatment Panel III)
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactating 2. Took medications affecting body weight 3. Medical comorbidities associated with weight loss or had severe psychiatric disorders (e.g., acute psychotic states, bipolar disorder, bulimia nervosa)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent weight loss at study end (1 year) | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes were assessed at baseline, after 3 weeks, after 27 weeks and after 1 year. 1. Attrition rates 2. Cardiovascular risk factors and psychological profile, measured using: 2.1. The Body Uneasiness Test-A 2.2. The Binge Eating test 2.3. Beck Depression Inventory 2.4. Beck Anxiety Inventory | — |
Countries
Italy
Outcome results
None listed